Exploring the Reasons for Dropouts of Injectable Contraceptive in Burdwan Municipal area, West Bengal, India: Beneficiaries’ and Service Providers’ Perspectives

Abstract Introduction: The inclusion of the Injectable Contraceptive, Antara Programme into family planning services signals a shift in the nation’s perspective and helps recipients achieve their goals for reproductive health. Depot medroxyprogesterone acetate (DMPA), marketed as Antara injection is considered a highly effective, long-acting reversible contraceptive, but it has limited acceptability. Hence the study was done to explore the reasons for dropouts of injection Antara from the perspective of beneficiaries and service providers in Antara clinics of Burdwan Municipal area of Purba-Bardhaman district, West-Bengal. Methodology: A descriptive type of qualitative research was conducted from February to July 2023 through in-depth interviews (IDIs) of 40 beneficiaries and focus group discussion (FGD) among 10 ANMs-Auxiliary Nurse Midwives. Data collection was done by audio recording of each IDI, FGD, and as well as by taking notes after achieving consent. Finally, inductive thematic analysis was carried out. Results: The reasons for dropouts of Antara injections among beneficiaries were found to be side effects (irregular bleeding, abdominal pain), lack of awareness, and familial barriers. Additionally, the significant challenge of recalling and visiting the clinic again for repeated injections was also recognized as a hindrance to sustained usage. Service providers cited stockouts, procurement issues, and lack of training and counseling as reasons for discontinuation. Both beneficiaries and service providers cited sociocultural factors, and lack of knowledge as a barrier to consistent use of Antara injections. Conclusions: The current study has shed some insight into the factors for the dropouts of Antara as a method of family planning. The study’s findings are anticipated to be applied in formulating regulations that will increase compliance with Antara and make the program more acceptable and consumer-friendly.

Authors

Institutions

Publication Details

Journal
Current Medical Issues
Published
2025-01-01
DOI
https://doi.org/10.4103/cmi.cmi_91_24
Primary Topic
Global Maternal and Child Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the Reasons for Dropouts of Injectable Contraceptive in Burdwan Municipal area, West Bengal, India: Beneficiaries’ and Service Providers’ Perspectives

Kaushik Mitra, Pramit Goswami, Pranita Taraphdar, Arif Hossain et al.
Current Medical Issues
Global Maternal and Child Health
article

Exploring the Reasons for Dropouts of Injectable Contraceptive in Burdwan Municipal area, West Bengal, India: Beneficiaries’ and Service Providers’ Perspectives

Kaushik Mitra, Pramit Goswami, Pranita Taraphdar, Arif Hossain, Suman Sannigrahi, Soumik Dandapat
article en

Abstract

Abstract Introduction: The inclusion of the Injectable Contraceptive, Antara Programme into family planning services signals a shift in the nation’s perspective and helps recipients achieve their goals for reproductive health. Depot medroxyprogesterone acetate (DMPA), marketed as Antara injection is considered a highly effective, long-acting reversible contraceptive, but it has limited acceptability. Hence the study was done to explore the reasons for dropouts of injection Antara from the perspective of beneficiaries and service providers in Antara clinics of Burdwan Municipal area of Purba-Bardhaman district, West-Bengal. Methodology: A descriptive type of qualitative research was conducted from February to July 2023 through in-depth interviews (IDIs) of 40 beneficiaries and focus group discussion (FGD) among 10 ANMs-Auxiliary Nurse Midwives. Data collection was done by audio recording of each IDI, FGD, and as well as by taking notes after achieving consent. Finally, inductive thematic analysis was carried out. Results: The reasons for dropouts of Antara injections among beneficiaries were found to be side effects (irregular bleeding, abdominal pain), lack of awareness, and familial barriers. Additionally, the significant challenge of recalling and visiting the clinic again for repeated injections was also recognized as a hindrance to sustained usage. Service providers cited stockouts, procurement issues, and lack of training and counseling as reasons for discontinuation. Both beneficiaries and service providers cited sociocultural factors, and lack of knowledge as a barrier to consistent use of Antara injections. Conclusions: The current study has shed some insight into the factors for the dropouts of Antara as a method of family planning. The study’s findings are anticipated to be applied in formulating regulations that will increase compliance with Antara and make the program more acceptable and consumer-friendly.

Current Medical IssuesVol. 23(1)
Burdwan Medical College & Hospital (IN)
Good health and well-being
Openalex Percentile: Top 99%
Global Maternal and Child Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.